Around 20% of newborns with neonatal seizures will later develop epilepsy by age one, according to a study by Copenhagen ...

Seizures in newborns are one of the most frequent acute neurological conditions among infants admitted to neonatal care units. A study published in Developmental Medicine & Child Neurology indicates ...

Seizures in newborns are one of the most frequent acute neurological conditions among infants admitted to neonatal care units.

Seizures in newborns are one of the most frequent acute neurological conditions among infants admitted to neonatal care units. A study published in ...

The World Health Organisation (WHO) says that around 50 million people across the world suffer from epilepsy which makes it one of the most common neurological diseases. Read on as an expert shares ...

Join the epilepsy community for Purple Day® on March 26, a global initiative to raise epilepsy awareness and support the millions of people living with epilepsy worldwide. Approximately 65 million ...

Biogen has bolstered its pipeline by licensing ex-US rights to a drug for Dravet syndrome – a rare form of epilepsy – from ...

Despite multiple calls made to the Scottish Ambulance Service, Natasha was told a clinician would call back while her ...

Biogen Inc. has agreed to pay as much as $550 million to develop and sell a drug to treat a genetic seizure disorder, the ...

Andrew Wilner speaks with fellow neurologist Karine Abou Khaled about her recent study on a 15-minute subdermal EEG with a simplified module for critically ill patients vs a full-head 24-hour EEG.

In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet ...